Stocklytics Platform
Asset logo  MDT
Medtronic PLC
MDT
59 / 100
S&P500
$81.50arrow_drop_down0.60%-$0.49

Performance History

Stocklytics logo
Key Stats
Open$83.57
Prev. Close$85.76
EPS2.76
Dividend$2.77
Next Earnings DateOct 11, 2024
Dividend Yield %3.40%
Market Cap$112.21B
PE Ratio29.49
LOWHIGH
Day Range81.22
84.11
52 Week Range68.84
91.00
Ratios
P/B Ratio2.05
Revenue$32.36B
Operating M. %15.51%
Earnings$3.67B
Earnings Growth %-2.83%
EBITDA Margin %29.37%
ROE %7.26%
EPS2.76

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$808.45
24H (%)arrow_drop_up0.69%
24H ($)$5.54
MARKET CAP$744.33B
PRICE$516.83
24H (%)arrow_drop_down0.86%
24H ($)-$4.51
MARKET CAP$476.05B
PRICE$149.70
24H (%)arrow_drop_down2.47%
24H ($)-$3.80
MARKET CAP$364.05B
PRICE$131.09
24H (%)0.00%
24H ($)-$0.01
MARKET CAP$332.27B

About Medtronic PLC (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Geoffrey Straub Martha
Headquarters
Dublin
Employees
95000
Exchange
NYSE
add Medtronic PLC to watchlist

Keep an eye on Medtronic PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the market capitalization of Medtronic PLC (MDT)?

Medtronic PLC (MDT) has a market capitalization of $112.21B. The average daily trading volume is 6.21M, indicating the stock's liquidity and investor engagement.

help
What is Medtronic PLC's (MDT) price per share?

The current price per share for Medtronic PLC (MDT) is $81.38. The stock has seen a price change of -$4.38 recently, indicating a -5.11% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Medtronic PLC (MDT)?

For Medtronic PLC (MDT), the 52-week high is $91, which is 11.82% from the current price. The 52-week low is $68.84, the current price is 18.22% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Medtronic PLC (MDT) a growth stock?

Medtronic PLC (MDT) has shown an average price growth of 0.41% over the past three years. It has received a score of 32 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Medtronic PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Medtronic PLC (MDT) stock price performance year to date (YTD)?

As of the latest data, Medtronic PLC (MDT) has a year-to-date price change of -1.76%. Over the past month, the stock has experienced a price change of 0.64%. Over the last three months, the change has been -2.93%. Over the past six months, the figure is 3.01%. Looking at a longer horizon, the five-year price change stands at -10.88%.

help
Is Medtronic PLC (MDT) a profitable company?

Medtronic PLC (MDT) has a net income of $3.68B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 60.59% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.51% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $32.36B, with a revenue growth rate of 3.64%, providing insight into the company's sales performance and growth. The gross profit is $19.61B. Operating income is noted at $6.32B. Furthermore, the EBITDA is $9.39B.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics, Inc. All rights reserved.

Stocklytics isn't a brokerage or dealer; it's supported by an affiliated investment adviser for an exchange traded fund. However, this adviser doesn't offer guidance to individual investors. None of the information on Stocklytics suggests buying or selling securities. The site and its newsletters aren't intended as investment advice. It's important to note that past performance isn't indicative of future results. Stocklytics doesn't guarantee the completeness or accuracy of its information. Also, the listed entities aren't affiliated with Stocklytics, LLC. Stock quotes come from InterActive Data, and Morningstar provides daily updated fundamental company data.

Stocklytics Discord public channelStocklytics X Social Media